newsfilter
← Latest News
GlobeNewswire·

Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call

  • Vivos Therapeutics, Inc. (NASDAQ: VVOS) will release its second quarter 2026 financial results after market close on Friday, August 14, 2026.
  • The company will host a conference call at 5:00 p.m. Eastern Time to review results, discuss strategic collaborations, and address near-term revenue growth and cash burn.
  • Investors can access the live call via phone dial-ins (800) 717-1738 (US) or (646) 307-1865 (international), with a webcast available at vivos.com/investors.
  • A replay of the call will be available until Friday, August 28, 2026, by dialing (844) 512-2921 (US) or (412) 317-6671 (international) using passcode 1174558.
  • Vivos develops FDA-cleared devices for obstructive sleep apnea (OSA), including the CARE technology for severe adult OSA and the DNA appliance for moderate-to-severe pediatric OSA.
  • The company's proprietary "Vivos Method" offers non-surgical, non-invasive treatment options targeting underlying physiological causes of breathing disorders.
  • The press release includes a cautionary note regarding forward-looking statements, highlighting risks such as regulatory scrutiny, financing challenges, potential product inefficacy, and market conditions.
  • Investor relations inquiries can be directed to Jennifer Hauser at jhauser@vivoslife.com or 720-927-3125.